4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-043972
General Counsel and Secretary sold 3,185 shares at $41.23 ($131,318)
- General Counsel and Secretary acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2025-03-20 | Option exercise | +6,250 | 84,914 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2025-03-21 | Sale | −3,185 | $41.23 | $131,318 | 81,729 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2025-03-20 | Option exercise · Restricted Stock Units | −6,250 | 18,750 | D | ||
| Open-market sales · 3,185 sh · avg $41.23 · $131,318 | |||||||
Loading xslF345X05/ownership.xml…